First Dose of BNT162b2 MRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2021 Apr 24

PMID 33893480

Citations 3

Authors

Patrick J Lillie

Paul OBrien

Michelle Lawtie

Steve Jessop

Nicholas J W Easom

Russell Patmore

Affiliations

Soon will be listed here.

Abstract

Over the first 2 months of 2021, vaccination coverage of staff at Hull Teaching Hospitals with BNT162b2 increased from 8.3% to 82.5% and was associated with a significant reduction in symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. The proportion of positive lateral flow tests from asymptomatic screening was maintained over this period.

Citing Articles

Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.

Wassie G, Ambelie Y, Adebabay T, Yeshiwas A, Fenta E, Abebe E PLoS One. 2024; 19(5):e0302531.

PMID: 38743644 PMC: 11093357. DOI: 10.1371/journal.pone.0302531.

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review.

Mohammed I, Nauman A, Paul P, Ganesan S, Chen K, Jalil S Hum Vaccin Immunother. 2022; 18(1):2027160.

PMID: 35113777 PMC: 8862168. DOI: 10.1080/21645515.2022.2027160.

Reported COVID-19 Vaccination Coverage and Associated Factors among Members of Athens Medical Association: Results from a Cross-Sectional Study.

Marinos G, Lamprinos D, Georgakopoulos P, Patoulis G, Vogiatzi G, Damaskos C Vaccines (Basel). 2021; 9(10).

PMID: 34696242 PMC: 8540685. DOI: 10.3390/vaccines9101134.

References

Houlihan C, Vora N, Byrne T, Lewer D, Kelly G, Heaney J . Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020; 396(10246):e6-e7. PMC: 7347344. DOI: 10.1016/S0140-6736(20)31484-7. View

Polack F, Thomas S, Kitchin N, Absalon J, Gurtman A, Lockhart S . Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383(27):2603-2615. PMC: 7745181. DOI: 10.1056/NEJMoa2034577. View

Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

Hall V, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A . COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021; 397(10286):1725-1735. PMC: 8064668. DOI: 10.1016/S0140-6736(21)00790-X. View